サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1206521

欧州のマラリア治療市場の2027年までの予測- 地域別分析- 治療タイプ別（抗マラリア薬、診断テスト）、投与経路別（経口、非経口）、エンドユーザー別（病院、専門クリニック、その他）

Europe Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Treatment Type (Antimalarial Agents, and Diagnostic Test); Route of Administration (Oral, and Parenteral); End User (Hospitals, Specialty Clinics, and Others)
出版日: | 発行: The Insight Partners | ページ情報: 英文 151 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
欧州のマラリア治療市場の2027年までの予測- 地域別分析- 治療タイプ別（抗マラリア薬、診断テスト）、投与経路別（経口、非経口）、エンドユーザー別（病院、専門クリニック、その他）
出版日: 2023年01月23日
発行: The Insight Partners
ページ情報: 英文 151 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のマラリア治療市場は、2022年の5億9,303万米ドルから2028年には7億8,575万米ドルに成長すると予測されています。2022年から2028年までのCAGRは4.8%と推定されています。

新薬とワクチンのパイプラインの延長が欧州のマラリア治療市場の牽引役となる

抗菌薬耐性は、マラリアなど多くの疾患に対する公衆衛生上の対応を脅かすものであり、新薬の研究開発はこの課題を克服するための最良の戦略です。これに伴い、抗マラリア薬/ワクチンのパイプラインはますます強固になってきています。官民パートナーシップは、マラリア治療市場における研究活動を加速させ、市場成長のための有利な機会を作り出しています。例えば、非営利団体であるMedicines for Malaria Venture（MMV）は、多くの製薬会社と協力し、新規治療法の開発によりマラリアの負担を軽減しています。2019年12月、Ipca LaboratoriesはMMVと共同で、新規抗マラリア共剤であるAtoguanilを開発しました。そのため、新薬やワクチンのパイプラインの延長が、欧州のマラリア治療市場を牽引すると期待されています。

欧州のマラリア治療市場の概要

欧州のマラリア治療市場には、英国、ドイツ、フランス、イタリア、スペイン、その他欧州が含まれます。2022年にはドイツが市場を独占しました。欧州疾病予防管理センターの報告書によると、2019年には欧州連合（EU）で8,641件のマラリア症例が登録され、そのうち8,638件（99%以上）がマラリア確定症例でした。さらに、マラリア症例のうち5,509例（99.8％）が旅行関連であり、そのうち2例がドイツで登録されました。ドイツでの症例は、媒介感染によって感染したものでした。EUは、効能の高いマラリアワクチンの開発・製造の促進を目指し、マラリアの撲滅を支援しています。例えば、2021年7月、マラリア撲滅イニシアチブを背景に、ドイツのBioNTech社は、この病気に対するmRNAベースのワクチン開発とアフリカでのmRNAワクチン生産の評価に焦点を当てたマラリアプロジェクトを発表しました。さらに、2022年9月、ドイツは国連合同エイズ計画（UNAIDS）と13億4,000万米ドル相当の協定を結び、2019年から国の拠出金を30％増額してエイズ、結核、マラリアと戦うことを目指します。さらに、2010年から2020年にかけて、endmalaria.orgの2020年報告書によると、マラリアの制御と撲滅を目指す総資金の69％を国際的なソースが提供しています。例えば、マラリアの制圧と撲滅のための総資金は33億米ドルで、ドイツは2億米ドルを拠出しています。

欧州のマラリア治療市場の収益と2028年までの予測

欧州のマラリア治療市場のセグメント化

欧州のマラリア治療市場は、治療法、薬剤タイプ、投与経路、流通チャネル、エンドユーザー、国に基づいてセグメント化されています。

治療法に基づき、欧州のマラリア治療市場は、処方薬、ワクチン、診断テスト、その他に区分されます。2022年には、診断テストセグメントが最大の市場シェアを占めています。処方薬セグメントはさらに、リン酸クロロキン、アルテミシニンベースの併用療法（ACT）、アトバキン・プログアニル、ドキシサイクリン入り硫酸キニーネ（クアラキン）、リン酸プリマキン、その他に分類されます。

薬剤の種類に基づき、欧州のマラリア治療市場はブランド品とジェネリック品に二分されます。2022年の市場シェアは、ジェネリック医薬品がより大きなシェアを占めています。

投与経路に基づき、欧州のマラリア治療市場は経口剤と非経口・静脈投与に二分されます。2022年には経口剤がより大きな市場シェアを占めています。

流通チャネルに基づき、欧州のマラリア治療市場は、直接入札、病院薬局、小売薬局、オンライン薬局、その他に区分されます。2022年には、直接入札セグメントが最も大きな市場シェアを占めました。

エンドユーザーに基づき、欧州のマラリア治療市場は、病院、専門クリニック、在宅医療、その他に区分されます。病院セグメントが2022年に最大の市場シェアを占めました。

国別では、欧州のマラリア治療市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に分類されます。地域別分析では、2022年にドイツが市場を独占しているとされています。

AdvaCare Pharma USA LLC、Cipla Ltd、GSK Plc、Lupin Ltd、Novartis AG、Sanofi SA、Sun Pharmaceutical Industries Ltd、Viatris Inc、Zydus Healthcare Ltdは、欧州のマラリア治療市場で事業を展開している主要企業の1つです。

目次

第1章 イントロダクション

第2章 重要なポイント

第3章 調査手法

  • カバレッジ
  • 2次調査
  • 1次調査

第4章 欧州のマラリア治療市場- 市場情勢

  • 欧州PEST分析
  • 専門家の見解

第5章 欧州のマラリア治療市場- 主要市場力学

  • 市場促進要因
    • マラリアに関する意識向上のための政府および民間セクターの取り組み
  • 市場抑制要因
    • 抗マラリア薬の偽造とその後の薬剤耐性
  • 市場機会
    • 新薬とワクチンのパイプラインの拡大
  • 今後の動向
    • 迅速な診断テスト
  • 影響分析

第6章 マラリア治療市場- 欧州の分析

  • 欧州のマラリア治療市場収益と予測・分析

第7章 欧州のマラリア治療市場分析- 治療タイプ別

  • 欧州のマラリア治療市場、治療タイプ別2021年・2028年（%）
  • 処方薬
  • ワクチン
  • 診断テスト
  • その他

第8章 欧州のマラリア治療市場分析- 薬剤タイプ別

  • 欧州のマラリア治療市場、薬剤タイプ別2021年・2028年（%）
  • ブランド品
  • ジェネリック医薬品

第9章 欧州のマラリア治療市場の分析- 投与経路別

  • 欧州のマラリア治療市場：投与経路別、2021年・2028年（%）
  • 経口投与
  • 非経口・静脈内投与モード

第10章 欧州のマラリア治療市場の分析- 流通チャネル別

  • 欧州のマラリア治療市場：流通チャネル別2021年・2028年（%）
  • 直接入札
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第11章 欧州のマラリア治療市場の分析- エンドユーザー別

  • 欧州のマラリア治療市場：エンドユーザー別、2021年・2028年（%）
  • 病院
  • 専門クリニック
  • ホームケア
  • その他

第12章 欧州のマラリア治療市場- 国別分析

    • 欧州
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他欧州

第13章 業界情勢

  • 無機的成長戦略
  • 有機的成長戦略

第14章 企業プロファイル

  • Zydus Healthcare Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Cipla Ltd
  • Viatris Inc
  • Lupin Ltd
  • AdvaCare Pharma USA LLC

第15章 付録

図表

List Of Tables

  • Table 1. Europe Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. Germany: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. Germany: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Germany: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Germany: Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Germany: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Germany: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. France: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. France: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. France: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 11. France: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 12. France: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. France: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. UK: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. UK: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. UK: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 17. UK: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 18. UK: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. UK: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Italy: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Italy: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Italy: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Italy: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Italy: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Italy: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Spain: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Spain: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Spain: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Spain: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Rest of Europe: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Rest of Europe: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Rest of Europe: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Rest of Europe: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Recent Inorganic Growth Strategies
  • Table 39. Recent Organic Growth Strategies in the Malaria Treatment Market
  • Table 40. Glossary of Terms

List Of Figures

  • Figure 1. Europe Malaria Treatment Market Segmentation
  • Figure 2. Europe Malaria Treatment Market Segmentation, By Country
  • Figure 3. Europe Malaria Treatment Market Overview
  • Figure 4. Europe Malaria Treatment Market, By Distribution Channel
  • Figure 5. Europe Malaria Treatment Market, By Country
  • Figure 6. Europe and PEST Analysis
  • Figure 7. Europe Malaria Treatment Market impact analysis of driver and restraints
  • Figure 8. Europe Malaria Treatment Market - Revenue Forecast and Analysis
  • Figure 9. Europe Malaria Treatment Market, by Treatment 2021 & 2028 (%)
  • Figure 10. Prescription Medication: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 11. Chloroquine Phosphate: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 12. Artemisinin- based Combination Therapies (ACTs): Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 13. Atovaquone-Proguanil: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 14. Quinine Sulphate (Qualaquin) with Doxycycline: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 15. Primaquine Phosphate: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 16. Others: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 17. Vaccines: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 18. Diagnostic Tests: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 19. Others: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 20. Europe Malaria Treatment Market, by Drug Type 2021 & 2028 (%)
  • Figure 21. Branded: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 22. Generics: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 23. Europe Malaria Treatment Market, by Route of Administration 2021 & 2028 (%)
  • Figure 24. Oral: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 25. Parenteral and Intravenous Mode: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 26. Europe Malaria Treatment Market, by Distribution Channel 2021 & 2028 (%)
  • Figure 27. Direct Tender: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 28. Hospital Pharmacies: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 29. Retail Pharmacies: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 30. Online Pharmacies: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 31. Others: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 32. Europe Malaria Treatment Market, by End User 2021 & 2028 (%)
  • Figure 33. Hospitals: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 34. Specialty Clinics: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 35. Homecare: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 36. Others: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 37. Europe: Malaria Treatment Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 38. Europe: Malaria Treatment Market, by Country, 2021 & 2028 (%)
  • Figure 39. Germany: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. France: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. UK: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Italy: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Spain: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Rest of Europe: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: TIPRE00025038

The Europe malaria treatment market is expected to grow from US$ 593.03 million in 2022 to US$ 785.75 million by 2028. It is estimated to register a CAGR of 4.8% from 2022 to 2028.

Extending Pipeline of New Drugs and Vaccines is Driving the Europe Malaria Treatment Market

Antimicrobial resistance threatens the public health response to many diseases, such as malaria, and the R&D of new medicines is the best strategy to overcome this challenge. With this, the antimalarial drug/vaccine pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities in the malaria treatment market, creating lucrative opportunities for the market growth. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, is working with many pharmaceutical companies to reduce the burden of malaria by developing novel treatment options. In December 2019, Ipca Laboratories collaborated with MMV to develop Atoguanil, a novel antimalarial coformulation. So, extending pipeline of new drugs and vaccines is expected to drive the Europe malaria treatment market .

Europe Malaria Treatment Market Overview

The Europe malaria treatment market includes the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022. According to the European Center for Disease Prevention and Control report, in 2019, 8,641 malaria cases were registered in the European Union (EU), among which 8,638 (>99%) were malaria-confirmed cases. Additionally, 5,509 cases (99.8%) of malaria cases were travel-related, among which two were registered in Germany. The cases in Germany were infected by vector-borne transmission. The EU supports eradicating malaria by aiming to facilitate the development and producing a highly efficacious malaria vaccine. For example, in July 2021, backed by the eradicate Malaria initiative, German company BioNTech announced a malaria project focusing on developing an mRNA-based vaccine against the disease and evaluating mRNA vaccine production in Africa. Moreover, in September 2022, Germany signed an agreement worth US$ 1.34 billion with The Joint United Nations Programme on HIV/AIDS (UNAIDS), aiming to fight AIDS, tuberculosis, and malaria with an increase of 30% of the country's contribution from 2019. Further, from 2010 to 2020, international sources provided 69% of total funding aiming for malaria control and elimination, as per the endmalaria.org 2020 report. For example, total funding for malaria control and elimination accounted for US$ 3.3 billion; Germany contributed US$ 0.2 billion.

Europe Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Europe Malaria Treatment Market Segmentation

The Europe malaria treatment market is segmented based on treatment, drug type, route of administration, distribution channel, end user, and country.

Based on treatment, the Europe malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. The diagnostic tests segment held the largest market share in 2022. The prescription medications segment is further categorized into chloroquine phosphate, artemisinin-based combination therapies (ACTs), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others.

Based on drug type, the Europe malaria treatment market is bifurcated into branded and generic. The generic segment held a larger market share in 2022.

Based on route of administration, the Europe malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment held a larger market share in 2022.

Based on distribution channel, the Europe malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on end user, the Europe malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe malaria treatment market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany dominated the market in 2022.

AdvaCare Pharma USA LLC, Cipla Ltd, GSK Plc, Lupin Ltd, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc, and Zydus Healthcare Ltd are among the leading companies operating in the Europe malaria treatment market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe malaria treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the malaria treatment market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Malaria Treatment Market - By Treatment
    • 1.3.2 Europe Malaria Treatment Market - By Drug Type
    • 1.3.3 Europe Malaria Treatment Market - By Route of Administration
    • 1.3.4 Europe Malaria Treatment Market - By Distribution Channel
    • 1.3.5 Europe Malaria Treatment Market - By End User
    • 1.3.6 Europe Malaria Treatment Market- By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Malaria Treatment Market- Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis
  • 4.3 Experts Opinion

5. Europe Malaria Treatment Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Government and Private Sector's Initiatives to Raise Awareness About Malaria
  • 5.2 Market Restraints
    • 5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance
  • 5.3 Market Opportunities
    • 5.3.1 Extending Pipeline of New Drugs and Vaccines
  • 5.4 Future Trends
    • 5.4.1 Rapid Diagnostic Tests
  • 5.5 Impact Analysis

6. Malaria Treatment Market- Europe Analysis

  • 6.1 Europe Malaria Treatment Market Revenue Forecast and Analysis

7. Europe Malaria Treatment Market Analysis - By Treatment

  • 7.1 Overview
  • 7.2 Europe Malaria Treatment Market, By Treatment 2021 & 2028 (%)
  • 7.3 Prescription Medications
    • 7.3.1 Overview
    • 7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.3 Chloroquine Phosphate
      • 7.3.3.1 Overview
      • 7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.4 Artemisinin- based Combination Therapies (ACTs)
      • 7.3.4.1 Overview
      • 7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.5 Atovaquone-Proguanil
      • 7.3.5.1 Overview
      • 7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline
      • 7.3.6.1 Overview
      • 7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.7 Primaquine Phosphate
      • 7.3.7.1 Overview
      • 7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.8 Others
      • 7.3.8.1 Overview
      • 7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4 Vaccines
    • 7.4.1 Overview
    • 7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.5 Diagnostic Tests
    • 7.5.1 Overview
    • 7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8. Europe Malaria Treatment Market Analysis - By Drug Type

  • 8.1 Overview
  • 8.2 Europe Malaria Treatment Market, By Drug Type 2021 & 2028 (%)
  • 8.3 Branded
    • 8.3.1 Overview
    • 8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Generics
    • 8.4.1 Overview
    • 8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)

9. Europe Malaria Treatment Market Analysis - By Route of Administration

  • 9.1 Overview
  • 9.2 Europe Malaria Treatment Market, By Route of Administration 2021 & 2028 (%)
  • 9.3 Oral
    • 9.3.1 Overview
    • 9.3.2 Oral Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4 Parenteral and Intravenous Mode
    • 9.4.1 Overview
    • 9.4.2 Parenteral and Intravenous Mode Market Revenue and Forecast to 2028 (US$ Mn)

10. Europe Malaria Treatment Market Analysis - By Distribution Channel

  • 10.1 Overview
  • 10.2 Europe Malaria Treatment Market, By Distribution Channel 2021 & 2028 (%)
  • 10.3 Direct Tender
    • 10.3.1 Overview
    • 10.3.2 Direct Tender Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.4 Hospital Pharmacies
    • 10.4.1 Overview
    • 10.4.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.5 Retail Pharmacies
    • 10.5.1 Overview
    • 10.5.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.6 Online Pharmacies
    • 10.6.1 Overview
    • 10.6.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.7 Others
    • 10.7.1 Overview
    • 10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

11. Europe Malaria Treatment Market Analysis - By End User

  • 11.1 Overview
  • 11.2 Europe Malaria Treatment Market, By End User 2021 & 2028 (%)
  • 11.3 Hospitals
    • 11.3.1 Overview
    • 11.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.4 Specialty Clinics
    • 11.4.1 Overview
    • 11.4.2 Specialty Clinics Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.5 Homecare
    • 11.5.1 Overview
    • 11.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.6 Others
    • 11.6.1 Overview
    • 11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

12. Europe Malaria Treatment Market - Country Analysis

  • 12.1 Overview
    • 12.1.2 Europe: Malaria Treatment Market, by Country, 2021 & 2028 (%)
      • 12.1.2.1 Germany: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.1.1 Overview
        • 12.1.2.1.2 Germany: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.1.3 Germany: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.1.3.1 Germany: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
        • 12.1.2.1.4 Germany: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.1.5 Germany: Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.1.6 Germany: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.1.7 Germany: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 12.1.2.2 France: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.2.1 Overview
        • 12.1.2.2.2 France: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.2.3 France: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.2.3.1 France: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
        • 12.1.2.2.4 France: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.2.5 France: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.2.6 France: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.2.7 France: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 12.1.2.3 UK: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.3.1 Overview
        • 12.1.2.3.2 UK: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.3.3 UK: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.3.3.1 UK: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
        • 12.1.2.3.4 UK: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.3.5 UK: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.3.6 UK: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.3.7 UK: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 12.1.2.4 Italy: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.4.1 Overview
        • 12.1.2.4.2 Italy: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.4.3 Italy: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.4.3.1 Italy: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
        • 12.1.2.4.4 Italy: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.4.5 Italy: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.4.6 Italy: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.4.7 Italy: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 12.1.2.5 Spain: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.5.1 Overview
        • 12.1.2.5.2 Spain: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.5.3 Spain: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.5.3.1 Spain: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
        • 12.1.2.5.4 Spain: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.5.5 Spain: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.5.6 Spain: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.5.7 Spain: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
      • 12.1.2.6 Rest of Europe: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.6.1 Overview
        • 12.1.2.6.2 Rest of Europe: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.6.3 Rest of Europe: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.6.3.1 Rest of Europe: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
        • 12.1.2.6.4 Rest of Europe: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.6.5 Rest of Europe: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.6.6 Rest of Europe: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.2.6.7 Rest of Europe: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Inorganic Growth Strategies
    • 13.2.1 Overview
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview

14. Company Profiles

  • 14.1 Zydus Healthcare Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Sun Pharmaceutical Industries Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Sanofi SA
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 GSK Plc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Novartis AG
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Cipla Ltd
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Viatris Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Lupin Ltd
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 AdvaCare Pharma USA LLC
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms